JP2012501318A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012501318A5 JP2012501318A5 JP2011524451A JP2011524451A JP2012501318A5 JP 2012501318 A5 JP2012501318 A5 JP 2012501318A5 JP 2011524451 A JP2011524451 A JP 2011524451A JP 2011524451 A JP2011524451 A JP 2011524451A JP 2012501318 A5 JP2012501318 A5 JP 2012501318A5
- Authority
- JP
- Japan
- Prior art keywords
- binding moiety
- eoc
- ovarian cancer
- protein
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000007571 Ovarian Epithelial Carcinoma Diseases 0.000 claims 18
- 206010033128 Ovarian cancer Diseases 0.000 claims 18
- 101150020367 SOX11 gene Proteins 0.000 claims 11
- 108020004999 messenger RNA Proteins 0.000 claims 6
- 238000004393 prognosis Methods 0.000 claims 5
- 238000001514 detection method Methods 0.000 claims 4
- 238000003745 diagnosis Methods 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 238000000034 method Methods 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 239000000090 biomarker Substances 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 230000001086 cytosolic effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 230000004083 survival effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0815846.1A GB0815846D0 (en) | 2008-09-01 | 2008-09-01 | diagnosis, prognosis and imaging of disease |
| GB0815846.1 | 2008-09-01 | ||
| PCT/GB2009/002098 WO2010023458A1 (en) | 2008-09-01 | 2009-09-01 | Method of diagnosing or prognosing epithelial ovarian cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012501318A JP2012501318A (ja) | 2012-01-19 |
| JP2012501318A5 true JP2012501318A5 (enExample) | 2012-10-18 |
Family
ID=39866018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011524451A Pending JP2012501318A (ja) | 2008-09-01 | 2009-09-01 | 上皮性卵巣癌の診断又は予後診断方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US20110217238A1 (enExample) |
| EP (1) | EP2329042B1 (enExample) |
| JP (1) | JP2012501318A (enExample) |
| CN (1) | CN102186994A (enExample) |
| ES (1) | ES2605254T3 (enExample) |
| GB (1) | GB0815846D0 (enExample) |
| WO (1) | WO2010023458A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2442919T3 (es) | 2007-03-27 | 2014-02-14 | Immunovia Ab | Firma/marcadores de proteínas para la detección de adenocarcinoma |
| GB0910620D0 (en) * | 2009-06-19 | 2009-08-05 | Immunovia Ab | Agents and uses thereof |
| WO2013013117A1 (en) | 2011-07-20 | 2013-01-24 | Mikroscan Technologies, Inc. | Network-based pathology system with desktop slide scanner |
| WO2013176958A1 (en) * | 2012-05-21 | 2013-11-28 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
| GB201319878D0 (en) * | 2013-11-11 | 2013-12-25 | Immunovia Ab | Method, Array and use thereof |
| WO2015073897A2 (en) | 2013-11-15 | 2015-05-21 | Mikroscan Technologies, Inc. | Geological scanner |
| WO2016069794A1 (en) | 2014-10-28 | 2016-05-06 | Mikroscan Technologies, Inc. | Microdissection viewing system |
| US20170097355A1 (en) * | 2015-10-06 | 2017-04-06 | University Of Washington | Biomarkers and methods to distinguish ovarian cancer from benign tumors |
| CN108085392A (zh) * | 2018-01-09 | 2018-05-29 | 山大生殖研发中心有限公司 | 上皮性卵巢癌的生物标志物及其用途 |
| GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070237770A1 (en) * | 2001-11-30 | 2007-10-11 | Albert Lai | Novel compositions and methods in cancer |
| KR20060031809A (ko) * | 2003-06-09 | 2006-04-13 | 더 리젠츠 오브 더 유니버시티 오브 미시간 | 암 치료 및 진단용 조성물 및 방법 |
| WO2005002417A2 (en) * | 2003-06-20 | 2005-01-13 | Avalon Pharmaceuticals, Inc. | Cancer -linked gene aas target for chemotherapy |
| BRPI0412110A (pt) * | 2003-07-02 | 2006-11-21 | Novartis Ag | genes regulados no cáncer ovariano como alvos prognósticos e terapêuticos |
| EP1806413A1 (en) * | 2006-01-06 | 2007-07-11 | Oligene GmbH | An in-vitro-method and means for determination of different tumor types and predicting success of surgical procedures in ovarian cancer |
-
2008
- 2008-09-01 GB GBGB0815846.1A patent/GB0815846D0/en not_active Ceased
-
2009
- 2009-09-01 ES ES09785026.7T patent/ES2605254T3/es active Active
- 2009-09-01 CN CN2009801412434A patent/CN102186994A/zh active Pending
- 2009-09-01 JP JP2011524451A patent/JP2012501318A/ja active Pending
- 2009-09-01 EP EP09785026.7A patent/EP2329042B1/en not_active Not-in-force
- 2009-09-01 US US13/061,530 patent/US20110217238A1/en not_active Abandoned
- 2009-09-01 WO PCT/GB2009/002098 patent/WO2010023458A1/en not_active Ceased
-
2015
- 2015-09-17 US US14/856,827 patent/US20160047815A1/en not_active Abandoned
-
2018
- 2018-06-08 US US16/003,731 patent/US20190018016A1/en not_active Abandoned
-
2022
- 2022-07-29 US US17/816,358 patent/US20220390452A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012501318A5 (enExample) | ||
| JP2009540803A5 (enExample) | ||
| RU2014108048A (ru) | Способ обнаружения рака поджелудочной железы | |
| JP2008249727A5 (enExample) | ||
| JP2013521763A5 (enExample) | ||
| NZ619883A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| JP6786499B2 (ja) | 膵癌のバイオマーカー | |
| ZA200805787B (en) | Detection of cancer by elevated levels of BCL-2 | |
| JP2010513901A5 (enExample) | ||
| BR112012019542A2 (pt) | "método para avaliar o estado renal em um indivíduo, medição de um ou mais biomarcadores, e, kit" | |
| NZ603492A (en) | Humanized anti-factor d antibodies and uses thereof | |
| MX337991B (es) | Metodo para detectar cancer. | |
| WO2008134526A3 (en) | Glycoprotein profiling of bladder cancer | |
| CA2792163A1 (en) | Biomarkers of osteoarthritis | |
| JP2011516038A5 (enExample) | ||
| JP2010207229A5 (enExample) | ||
| US10724097B2 (en) | Methods and compositions for diagnosis and management of diabetes and metabolic syndrome | |
| JP2011517937A5 (enExample) | ||
| JP2013531784A5 (enExample) | ||
| ES2861440T5 (en) | Use of nucleosome-transcription factor complexes for cancer detection | |
| CN103487588B (zh) | Galectin-4蛋白在制备巨大肝癌术后预后评估试剂盒中的应用 | |
| JP2011516037A5 (enExample) | ||
| CN107110848B (zh) | 以脱氧羟腐胺缩赖氨酸合酶基因作为指标使用的动脉硬化及癌的检测方法 | |
| NZ593392A (en) | Biomarker for detecting bladder cancer | |
| JP6066220B2 (ja) | ＩｇＡ凝集体の検出方法およびＩｇＡ腎症の検査方法 |